Factor X antibody
![Research Use Only](static/images/certificates/ruo.jpg)
GTX110300
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetF10
Overview
- SupplierGeneTex
- Product NameFactor X antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.05 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID2159
- Target nameF10
- Target descriptioncoagulation factor X
- Target synonymscoagulation factor X; factor X; factor Xa; FX; FXA; prothrombinase; Stuart-Prower factor
- HostRabbit
- IsotypeIgG
- Protein IDP00742
- Protein NameCoagulation factor X
- Scientific DescriptionThis gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. [provided by RefSeq]
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Anticoagulants inhibit proteolytic clearance of plasma amyloid beta. Yang L et al., 2018 Jan 19, OncotargetRead more
- A plasma proteolysis pathway comprising blood coagulation proteases. Yang L et al., 2016 Jul 5, OncotargetRead more
- A hexon-specific PEGylated adenovirus vector utilizing blood coagulation factor X. Matsui H et al., 2012 May, BiomaterialsRead more